NeuroPace is the developer and manufacturer of the RNS System, a proven treatment option for adults who have disabling seizures that are not controlled by medication. The RNS System is the only medical device that is smart enough to respond to what’s happening in the brain to stop seizures at their source.
Safety Information
The RNS® System is an adjunctive therapy in reducing the frequency of seizures in individuals 18 years of age or older with partial onset seizures who have undergone diagnostic testing that localized no more than 2 epileptogenic foci, are refractory to two or more antiepileptic medications, and currently have frequent and disabling seizures.
Please refer to the product labeling for a detailed disclosure of specific indications, contraindications, warnings, precautions and adverse events. Rx only.
Location: United States, California, Mountain View
Employees: 51-200
Phone: (866) 726-3876
Total raised: $150.3M
Founded date: 1997
Investors 5
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| 06.07.2021 | New Enterp... | nea.com |
| - | UCLA Ventu... | ventures.u... |
| - | CRG | crglp.com |
| - | OrbiMed | orbimed.co... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 03.07.2021 | Grant | $9.3M | - |
| 31.08.2020 | - | $67M | - |
| 24.10.2017 | - | $74M | - |
Mentions in press and media 23
| Date | Title | Description | Source |
| 05.03.2024 | NeuroPace Announces Record Full Year 2023 Revenue of $65.4 M... | - | globenewsw... |
| 12.10.2022 | NeuroPace announces first patient implant in trial of neur... | The NeuroPace RNS system (Image from NeuroPace) NeuroPace (Nasdaq:NPCE) announced that the first pat... | massdevice... |
| 12.01.2022 | NeuroPace Announces Preliminary Unaudited Fourth Quarter and... | MOUNTAIN VIEW, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercia... | marketscre... |
| 12.01.2022 | NeuroPace : Announces Preliminary Unaudited Fourth Quarter a... | NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue Mountain View, C... | marketscre... |
| 22.12.2020 | Epileptic Seizures Aren’t Entirely Random. Discovery May Lea... | forbes.com... | |
| 04.09.2020 | StartUPDATES: New developments from healthcare startups | Self-insured employers, including several Fortune 500 companies, leverage Carrum Health’s technology... | medcitynew... |
| 31.08.2020 | NeuroPace : Raises $67 Million Financing to Support Commerci... | NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced it has raised $6... | marketscre... |
| 31.08.2020 | NeuroPace Grabs $67M Funding | MOUNTAIN VIEW, CA, NeuroPace announced that it had raised $67 million in a funding round led by Ac... | vcnewsdail... |
| 31.08.2020 | NeuroPace Raises $67M in Funding | NeuroPace, Inc., a Mountain View, Calif.-based medical technology company, raised $67m in funding. I... | finsmes.co... |
| 31.08.2020 | NeuroPace Raises $67 Million Financing to Support Commercial... | - | orbimed.co... |
Show more